Pharma company stocks tumbled after Donald Trump announced a plan to reduce U.S. drug prices, but regained some ground on belief the plan would be hard to implement Drug prices are expected to decline ...

On May 22 nd, the Departments of Health and Human Services (HHS), Treasury and Labor announced a joint effort to advance ...

The president has signed an executive order stating that the US will institute a “most-favored-nation” policy, whereby the US will pay the same price for a drug as the nation that pays the lowest ...

Following through on President Donald Trump’s “most favored nation” policy, the HHS is about to drop a drug pricing hammer on ...

The company has started to add bearish views on Wall Street as the healthcare giant's business practices draw public scrutiny, risking its prospects, worsened by its recent leadership change. Bank of ...

We can move toward free market reforms in drug pricing. We must overturn the current perverse incentives that favor the ...

It began in 2020 with a coordinated push to generate public backlash to lockdowns. The ultimate aim was restoring normalcy, ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

President Donald Trump recently signed an executive order aimed at lowering prescription drug prices. However, experts told KFF Health News the policy’s rollout reveals a slow, conditional path that ...

As part of a broader resurgence in pharmaceutical pricing reform and manufacturing policies in 2025, President Donald Trump ...

Following President Donald Trump's most favored nation executive order, HHS and CMS have released the target price for ...

Jamie Baumgartner, Jonathan Grinstein, and John Wilkerson go behind the headlines to discuss the implications of personalized gene-editing therapies, more HHS policy and funding updates, and the ...